UK markets closed

Hemogenyx Pharmaceuticals Plc (HEMO.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
1.5650-0.0020 (-0.13%)
At close: 04:20PM BST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-6,691
-6,691
-3,979
-5,099
-2,082
Depreciation & amortisation
645.681
645.681
195.246
126.34
106.753
Stock-based compensation
242.836
242.836
17.575
153.355
363.104
Change in working capital
-833.596
-833.596
242.59
101.387
-57.135
Other working capital
-6,223
-6,223
-3,340
-3,445
-1,971
Other non-cash items
537.487
537.487
617.03
2,118
30.669
Net cash provided by operating activities
-6,106
-6,106
-2,911
-2,627
-1,798
Cash flows from investing activities
Investments in property, plant and equipment
-11.918
-117.285
-428.945
-817.998
-173.047
Purchases of investments
0
0
-1.908
-138.913
-
Net cash used for investing activities
-31.941
-31.941
-420.254
-938.953
-169.682
Net change in cash
-1,688
-1,688
-3,432
5,211
1,244
Cash at beginning of period
2,533
2,533
6,841
1,812
498.679
Cash at end of period
1,248
1,248
2,533
6,841
1,812
Free cash flow
Operating cash flow
-6,106
-6,106
-2,911
-2,627
-1,798
Capital expenditure
-11.918
-117.285
-428.945
-817.998
-173.047
Free cash flow
-6,223
-6,223
-3,340
-3,445
-1,971